European and United States share a common, yet highly disturbing cancer statistic: 20-40% of cancer patients die from malnutrition and not the cancer itself. CellMark has taken yet another step in reaching its highly ambitious goal of cutting those deaths in half through its Medical Nutrition line as well as its ever increasing presence and influence in the international nutrition world. CellMark Biopharma proudly announced that [Erica Boliek](http://www.cellmarkbiopharma.com/about-us/management/), Chief of Research and Development, has been added to the editorial board as a reviewer for The European Society for Clinical Nutrition and Metabolism Journal of Clinical Nutrition.
The European Society of Clinical Nutrition and Metabolism official journal is [Clinical Nutrition](http://www.journals.elsevier.com/clinical-nutrition/) with an impact factor 3.41, making it #12 among the 59 journals of Nutrition and Dietetics. It is an international journal providing essential scientific information on nutritional and metabolic care and the relationship between nutrition and disease both in the setting of basic science and clinical practice. As a reviewer for the journal, Ms. Boliek, will be a part of the peer-reviewing process that subjects scientific research papers to revision based on the scientific merit and validity of the article and its methodology before being published.
Ms. Erica Boliek, M.M.S., PA-C, is a clinician-scientist who has spent her time cultivating broad experience in various research fields and medical nutrition development. Among her other credentials are Board Certified Athletic Trainer, CPCC (certified professional cancer coach) and manuscript reviewer and editor for the Journal of Athletic Training and the American College of Sports Medicine. She has published works in the Journal of American Academy of Physician Assistants and lectured globally.
CellMark Biopharma congratulates Erica Boliek and is proud to have her as part of the management team at the company fostering a better today and future for everyone.
INDUSTRY KEYWORDS: Biotechnology, Cancer, cancer super drink, Clinical Trials, Daniel Von Hoff, Stand Up To Cancer, Oncology, Pharmaceutical, Research, Health, CellMark Biopharma, Derek Vest, Kalos Therapeutics, Erica Boliek, Dr. Stan Headley, Craig Pisaris-Henderson, CellAssure, Cognify
